Jennerex appoints new VP of corporate development
This article was originally published in Scrip
Executive Summary
Jennerex, a US clinical-stage biotherapeutics company focused on oncolytic products, has appointed Samantha Miller vice-president of corporate development. Ms Miller brings more than 15 years' experience in biotechnology and pharmaceutical business development to the role, having previously worked at Anesiva, Theravance, Scios Pharmaceuticals, Onyx Pharmaceuticals and Procter & Gamble Pharmaceuticals.